Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports-Reference-Cited by-同舟云学术

Seborrhoeic dermatitis and sebopsoriasis developing in patients on dupilumab: Two case reports

Published:2020-05-09 Issue:8 Volume:8 Page:1458-1460
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clin Case Rep

Author:

Al‐Janabi Ali¹²^ORCID,Marsland Alexander M.¹²

Affiliation:

1. The Dermatology Centre Salford Royal NHS Foundation Trust Manchester NIHR Biomedical Research Centre Manchester Academic Health Science Centre Salford UK

2. Division of Musculoskeletal and Dermatological Sciences School of Biological Sciences Faculty of Biology, Medicine and Health The University of Manchester Salford UK

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.2871

Reference11 articles.

1. Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis

2. Adverse events of Dupilumab in adults with moderate-to-severe atopic dermatitis: A meta-analysis

3. Occurrence of psoriasiform eruption during dupilumab therapy for adult atopic dermatitis: A case series

4. Clinical and histopathological characterization of paradoxical head and neck erythema in patients with atopic dermatitis treated with dupilumab: a case series

5. Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical Psoriasis: An Updated Review of Clinical Features, Pathogenesis, and Treatment Options;Journal of Investigative Dermatology;2024-07

2. More yeast, more problems?: reevaluating the role of Malassezia in seborrheic dermatitis;Archives of Dermatological Research;2024-03-12

3. Seborrhoeic Dermatitis;Rook's Textbook of Dermatology;2024-02-20

4. A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis;Dermatitis®;2024-02-01

5. Efficacy of tyrosine-kinase-2 and phosphodiesterase-4 inhibitors for scalp psoriasis: a systematic review and meta-analysis;Current Medical Research and Opinion;2023-12-13